In clinical trials, vaccines against study to assess the effectiveness and safety of COVID- 19 mRNA vaccines in end- the proportion of receptor- binding the S1 subunit SARS- CoV- 2… Click to show full abstract
In clinical trials, vaccines against study to assess the effectiveness and safety of COVID- 19 mRNA vaccines in end- the proportion of receptor- binding the S1 subunit SARS- CoV- 2 spike protein evaluated humoral responses in participants R/Obi within
               
Click one of the above tabs to view related content.